Quantcast

Latest Ribbon symbolism Stories

2014-03-25 12:29:41

Perjeta and Kadcyla are Reshaping the Treatment Algorithm for Patients with HER2-Positive Breast Cancer, According to Findings from Decision Resources Group BURLINGTON, Mass., March 25, 2014 /PRNewswire/ -- Decision Resources Group finds that efficacy more than any other factors drives oncologists' prescribing of targeted therapies for breast cancer and, according to the majority of surveyed oncologists, the escalating overall cost of drug treatment for breast cancer has little or no impact...

2014-03-25 08:29:51

Inspired to save the lives of Coachella Valley cancer patients, BIGHORN Behind a Miracle (BAM) reached an exciting milestone of raising $1 million at their kick-off party, A Night of Miracles, for BIGHORN BAM Week that also includes a Caddy Auction and Golf Tournament. PALM DESERT, Calif., March 25, 2014 /PRNewswire/ -- BIGHORN BAM Founder Selby Dunham took her breast cancer survivor story and decided to give back to the hospital and community she loves so much. In the past 7...

2014-03-24 20:22:55

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/czqbv2/investigation) has announced the addition of the "Investigation Report on China Trastuzumab Market, 2009-2018" [http://www.researchandmarkets.com/research/czqbv2/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Trastuzumab is a monoclonal antibody that interferes with the HER2/neu receptor. Its main...

2014-03-22 23:04:05

Pretty In Pink Foundation achieves business milestone while providing hope and healing to underinsured and uninsured North Carolinians diagnosed with breast cancer Raleigh, NC (PRWEB) March 22, 2014 Headquartered in Raleigh, North Carolina under the leadership of its Founder Dr. Lisa Tolnitch, Pretty In Pink Foundation (http://www.prettyinpinkfoundation.org) proudly celebrates ten years of serving North Carolinian women and men diagnosed with breast cancer who are unable to pay for...

Mammograms Needed More Often For One-Third Of Women
2014-03-22 07:07:50

April Flowers for redOrbit.com - Your Universe Online While three-year intervals between mammograms are appropriate for most women, a new study from the UK NHS Breast Screening Program has found that one-third of women are at a higher risk of developing cancer. These women, according to the report delivered this week at the 9th European Breast Cancer Conference (EBCC-9), might benefit from more frequent mammograms. Professor Gareth Evans, from the University of Manchester, reported that...

2014-03-20 23:22:02

Entinostat is being investigated in patients with advanced hormone receptor-positive breast cancer by the ECOG-ACRIN Cancer Research Group in its latest trial, E2112. Philadelphia, PA, and Waltham, MA (PRWEB) March 20, 2014 The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Syndax Pharmaceuticals, Inc., announced today that patient recruitment has begun for E2112, a randomized phase III clinical trial of Syndax’s entinostat in treatment of patients with advanced breast cancer. The...

2014-03-20 23:00:50

Kim Melcher named Deputy Director of ABCD: After Breast Cancer Diagnosis. Glendale, WI (PRWEB) March 20, 2014 As part of its continued expansion, ABCD: After Breast Cancer Diagnosis announced today that Kim Melcher will serve as its first Deputy Director. Most recently the Coordinator for the Wisconsin Well Woman Program for Milwaukee County (suburban communities), Kim brings over 15 years of public health experience to this new role, including work with multi-state hospital systems,...

2014-03-19 23:30:24

New Jersey Breast Center leading the way in early detection of breast cancer awarded 2nd service excellence honor second year in a row. Montclair, NJ (PRWEB) March 19, 2014 Montclair Breast Center, a uniquely comprehensive facility providing annual screening and diagnostic 3D mammography (breast tomosynthesis), breast physical exams, breast ultrasound, breast MRI risk assessment and breast health education has earned the coveted Angie’s List Super Service Award, reflecting an exemplary...

2014-03-19 23:00:54

ReportsnReports.com adds “Cancer Gene Therapy Market Analysis” report to its research database. The gene therapy drugs which have been approved till date are Gendicine & Rexin-G. Dallas, TX (PRWEB) March 20, 2014 The gene therapy market has undergone a series of transformation from the initial days of research to the current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the...

2014-03-19 08:29:07

Data Presented at 9th European Breast Cancer (EBCC-9) Symposium Highlights Comprehensive Body of Clinical Evidence for Oncotype DX REDWOOD CITY, Calif., March 19, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of multiple Oncotype DX® breast cancer studies at the 9(th) European Breast Cancer Conference (EBCC-9), which takes place March 19-21 in Glasgow, Scotland, United Kingdom. New data will include an independently conducted physician survey that...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related